<?xml version="1.0" encoding="UTF-8"?>
<p>The economic benefit of vaccination has confirmed by various studies using modeling approaches (
 <xref rid="ref-18" ref-type="bibr">Maciosek et al., 2006</xref>). Examples of studies investigated the economic benefits of from both health service and societal perspectives for individuals aged 50 years and older (
 <xref rid="ref-29" ref-type="bibr">Turner et al., 2006</xref>; 
 <xref rid="ref-1" ref-type="bibr">Aballéa et al., 2007</xref>). Another study developed mathematical models to assess the cost benefit of sharing pediatric and adult flu vaccines (
 <xref rid="ref-10" ref-type="bibr">Chen, 2017</xref>). Influenza vaccination can also benefit the younger population. Scholars estimate the clinical impact of introducing childhood influenza vaccine in England and Wales (
 <xref rid="ref-24" ref-type="bibr">Pitman, White &amp; Sculpher, 2012</xref>). They further develop a dynamic transmission model to assess the cost-effectiveness for the new vaccination policy in the same region (
 <xref rid="ref-23" ref-type="bibr">Pitman, Nagy &amp; Sculpher, 2013</xref>). Other scholars analyzed the impact of immunizing school-age children to economic loses and domestic transmission (
 <xref rid="ref-21" ref-type="bibr">Neuzil, Hohlbein &amp; Zhu, 2002</xref>; 
 <xref rid="ref-35" ref-type="bibr">Yoo et al., 2013</xref>).
</p>
